156 related articles for article (PubMed ID: 19779934)
1. Association of clinicopathological features with UbcH10 expression in colorectal cancer.
Chen S; Chen Y; Hu C; Jing H; Cao Y; Liu X
J Cancer Res Clin Oncol; 2010 Mar; 136(3):419-26. PubMed ID: 19779934
[TBL] [Abstract][Full Text] [Related]
2. RNA interference-mediated silencing of UBCH10 gene inhibits colorectal cancer cell growth in vitro and in vivo.
Chen SM; Jiang CY; Wu JY; Liu B; Chen YJ; Hu CJ; Liu XX
Clin Exp Pharmacol Physiol; 2010 May; 37(5-6):525-9. PubMed ID: 20529090
[TBL] [Abstract][Full Text] [Related]
3. UbcH10 expression can predict prognosis and sensitivity to the antineoplastic treatment for colorectal cancer patients.
Cacciola NA; Calabrese C; Malapelle U; Pellino G; De Stefano A; Sepe R; Sgariglia R; Quintavalle C; Federico A; Bianco A; Uchimura Bastos A; Milone M; Bellevicine C; Milone F; Carlomagno C; Selvaggi F; Troncone G; Fusco A; Pallante P
Mol Carcinog; 2016 May; 55(5):793-807. PubMed ID: 25917796
[TBL] [Abstract][Full Text] [Related]
4. UbcH10 expression may be a useful tool in the prognosis of ovarian carcinomas.
Berlingieri MT; Pallante P; Guida M; Nappi C; Masciullo V; Scambia G; Ferraro A; Leone V; Sboner A; Barbareschi M; Ferro A; Troncone G; Fusco A
Oncogene; 2007 Mar; 26(14):2136-40. PubMed ID: 17016443
[TBL] [Abstract][Full Text] [Related]
5. UbcH10 overexpression in human lung carcinomas and its correlation with EGFR and p53 mutational status.
Pallante P; Malapelle U; Berlingieri MT; Bellevicine C; Sepe R; Federico A; Rocco D; Galgani M; Chiariotti L; Sanchez-Cespedes M; Fusco A; Troncone G
Eur J Cancer; 2013 Mar; 49(5):1117-26. PubMed ID: 23102841
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological relevance of UbcH10 in breast cancer.
Fujita T; Ikeda H; Kawasaki K; Taira N; Ogasawara Y; Nakagawara A; Doihara H
Cancer Sci; 2009 Feb; 100(2):238-48. PubMed ID: 19038004
[TBL] [Abstract][Full Text] [Related]
7. UbcH10 a Major Actor in Cancerogenesis and a Potential Tool for Diagnosis and Therapy.
Presta I; Novellino F; Donato A; La Torre D; Palleria C; Russo E; Malara N; Donato G
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32192022
[TBL] [Abstract][Full Text] [Related]
8. UbcH10 overexpression increases carcinogenesis and blocks ALLN susceptibility in colorectal cancer.
Li SZ; Song Y; Zhang HH; Jin BX; Liu Y; Liu WB; Zhang XD; Du RL
Sci Rep; 2014 Nov; 4():6910. PubMed ID: 25376843
[TBL] [Abstract][Full Text] [Related]
9. UbcH10 overexpression may represent a marker of anaplastic thyroid carcinomas.
Pallante P; Berlingieri MT; Troncone G; Kruhoffer M; Orntoft TF; Viglietto G; Caleo A; Migliaccio I; Decaussin-Petrucci M; Santoro M; Palombini L; Fusco A
Br J Cancer; 2005 Aug; 93(4):464-71. PubMed ID: 16106252
[TBL] [Abstract][Full Text] [Related]
10. [UbcH10 expression in hepatocellular carcinoma and its clinicopathological significance].
Han SS; Liu QG; Yao YM; Sun H; Zan XF; Song T; Yang X; Zheng X
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Feb; 31(2):280-4. PubMed ID: 21354912
[TBL] [Abstract][Full Text] [Related]
11. Expression of ubiquitin-conjugating enzyme E2C/UbcH10 in astrocytic tumors.
Jiang L; Huang CG; Lu YC; Luo C; Hu GH; Liu HM; Chen JX; Han HX
Brain Res; 2008 Mar; 1201():161-6. PubMed ID: 18331723
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of the E2 ubiquitin-conjugating enzyme UbcH10 causes chromosome missegregation and tumor formation.
van Ree JH; Jeganathan KB; Malureanu L; van Deursen JM
J Cell Biol; 2010 Jan; 188(1):83-100. PubMed ID: 20065091
[TBL] [Abstract][Full Text] [Related]
13. UbcH10 expression provides a useful tool for the prognosis and treatment of non-small cell lung cancer.
Zhao L; Jiang L; Wang L; He J; Yu H; Sun G; Chen J; Xiu Q; Li B
J Cancer Res Clin Oncol; 2012 Nov; 138(11):1951-61. PubMed ID: 22760214
[TBL] [Abstract][Full Text] [Related]
14. Expression of UbcH10 in pancreatic ductal adenocarcinoma and its correlation with prognosis.
Zhao ZK; Wu WG; Chen L; Dong P; Gu J; Mu JS; Yang JH; Liu YB
Tumour Biol; 2013 Jun; 34(3):1473-7. PubMed ID: 23355337
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical analysis of the ubiquitin-conjugating enzyme UbcH10 in lung cancer: a useful tool for diagnosis and therapy.
Perrotta I; Bruno L; Maltese L; Russo E; Donato A; Donato G
J Histochem Cytochem; 2012 May; 60(5):359-65. PubMed ID: 22388643
[TBL] [Abstract][Full Text] [Related]
16. Antitumor effects of hsa‑miR661‑3p on non‑small cell lung cancer in vivo and in vitro.
Lu J; Gu X; Liu F; Rui Z; Liu M; Zhao L
Oncol Rep; 2019 May; 41(5):2987-2996. PubMed ID: 30896844
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of ubiquitin-conjugating enzyme E2C/UbcH10 expression by RNA interference inhibits glioma cell proliferation and enhances cell apoptosis in vitro.
Jiang L; Bao Y; Luo C; Hu G; Huang C; Ding X; Sun K; Lu Y
J Cancer Res Clin Oncol; 2010 Feb; 136(2):211-7. PubMed ID: 19657671
[TBL] [Abstract][Full Text] [Related]
18. UbcH10 is the cancer-related E2 ubiquitin-conjugating enzyme.
Okamoto Y; Ozaki T; Miyazaki K; Aoyama M; Miyazaki M; Nakagawara A
Cancer Res; 2003 Jul; 63(14):4167-73. PubMed ID: 12874022
[TBL] [Abstract][Full Text] [Related]
19. Expression significance of Emi1, UBCH10 and CyclinB1 in esophageal squamous cell carcinoma.
Li H; Yang C; Chen K; Sun M
Pathol Oncol Res; 2023; 29():1611081. PubMed ID: 37168048
[TBL] [Abstract][Full Text] [Related]
20. UbcH10 expression in human lymphomas.
Troncone G; Guerriero E; Pallante P; Berlingieri MT; Ferraro A; Del Vecchio L; Gorrese M; Mariotti E; Iaccarino A; Palmieri EA; Zeppa P; Palombini L; Fusco A
Histopathology; 2009 May; 54(6):731-40. PubMed ID: 19438748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
